HHMI
SNDK

Howard Hughes Medical Institute’s SANDISK CORP SNDK Stock Holding History

Howard Hughes Medical Institute’s Portfolio SNDK Stock Details SNDK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-35,014
Closed -$2.66M – 192
2016
Q1 		$2.66M Buy
35,014
+5,155
+17% +$372K 0.59% 43
2015
Q4 		$2.27M Sell
29,859
-1,131
-4% -$82.8K 0.35% 43
2015
Q3 		$1.68M Sell
30,990
-15,388
-33% -$850K 0.32% 45
2015
Q2 		$2.7M Sell
46,378
-4,390
-9% -$294K 0.57% 45
2015
Q1 		$3.23M Buy
50,768
+13,376
+36% +$1.09M 0.44% 41
2014
Q4 		$3.66M Buy
37,392
+13,303
+55% +$1.27M 0.98% 31
2014
Q3 		$2.36M Buy
24,089
+10,116
+72% +$990K 0.53% 38
2014
Q2 		$1.46M Buy
13,973
+585
+4% +$53.1K 0.25% 37
2014
Q1 		$1.09M Buy
13,388
+136
+1% +$10K 0.15% 39
2013
Q4 		$935K Buy
13,252
+1,615
+14% +$109K 0.14% 41
2013
Q3 		$693K Buy
11,637
+1,498
+15% +$88K 0.11% 44
2013
Q2 		$619K Buy
+10,139
New +$578K 0.2% 52

Other funds holding SNDK

OAM
Orinda Asset Management Lafayette, California $48.7M AUM 26.85% 1-Year Est. Return

Howard Hughes Medical Institute's SNDK Position: Q2 2016 in Review

Howard Hughes Medical Institute sold out of SANDISK CORP (SNDK) in Q2 2016, closing a stake of 35,014 shares — an estimated $2.66M sold.

Howard Hughes Medical Institute first reported a position in SNDK in Q2 2013 and held it in 12 quarters. The position peaked at $3.66M in Q4 2014. 1 fund tracked by Wall St. Rank holds SNDK as of Q2 2016.

  • Howard Hughes Medical Institute reported no remaining SANDISK CORP position as of Q2 2016 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 35,014 SANDISK CORP shares in Q2 2016, an estimated $2.66M.
  • Howard Hughes Medical Institute first reported a position in SANDISK CORP in Q2 2013 and held it in 12 quarters.
  • Howard Hughes Medical Institute's SANDISK CORP position peaked at $3.66M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held SANDISK CORP as of Q2 2016.

Based on Howard Hughes Medical Institute's 13F filing for Q2 2016, filed 3 Aug 2016.